Furthermore, Setiawan et al. 7 applied PET to examine a marker of neuroinflammation, translocator protein (TSPO) binding in vivo, in order to determine the neuroinflammatory hypothesis of MDD. The gene discussed is TSPO; the disease is major depressive disorder.